Misplaced Pages

Felbinac: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 21:34, 8 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,084 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').← Previous edit Latest revision as of 22:11, 10 January 2025 edit undoArthurfragoso (talk | contribs)Extended confirmed users, Template editors4,591 edits dark mode fix 
(38 intermediate revisions by 27 users not shown)
Line 1: Line 1:
{{Short description|Topical NSAID medication}}
{{drugbox
{{Drugbox
| Verifiedfields = changed
| UNII_Ref = {{fdacite|changed|FDA}} | Watchedfields = changed
| verifiedrevid = 443752362
| UNII = 94WNJ5U8L7
| IUPAC_name = biphenyl-4-ylacetic acid
| verifiedrevid = 415333733
| image = Felbinac.svg
| IUPAC_name = biphenyl-4-ylacetic acid
| image_class = skin-invert-image
| image = Felbinac.svg

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|felbinac}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = P
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = Topical

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 5728-52-9
| ATC_prefix = M02
| ATC_suffix = AA08
| PubChem = 3332
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB07477
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3215 | ChemSpiderID = 3215
| UNII_Ref = {{fdacite|correct|FDA}}
| InChI = 1/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16)
| UNII = 94WNJ5U8L7
| InChIKey = QRZAKQDHEVVFRX-UHFFFAOYAC
| KEGG_Ref = {{keggcite|correct|kegg}}
| smiles = O=C(O)Cc1ccc(cc1)c2ccccc2
| KEGG = D01675
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 31597
| ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 413965 | ChEMBL = 413965

<!--Chemical data-->
| C=14 | H=12 | O=2
| smiles = O=C(O)Cc1ccc(cc1)c2ccccc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) | StdInChI = 1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QRZAKQDHEVVFRX-UHFFFAOYSA-N | StdInChIKey = QRZAKQDHEVVFRX-UHFFFAOYSA-N
| CAS_number = 5728-52-9
| ATC_prefix = M02
| ATC_suffix = AA08
| ChEBI = 31597
| PubChem = 3332
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB07477
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01675
| C=14|H=12|O=2
| molecular_weight = 212.244 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = P
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = Topical
}} }}
'''Felbinac''' (]) (or '''biphenylylacetic acid''') is a ] medicine, belonging to the family of medicines known as ] (NSAIDs) of the arylpropionic acid class, which is used to treat muscle inflammation and ]. It is an active metabolite of ].<ref name="KTWE1980">{{cite journal | author=Kohler C, Tolman E, Wooding W, Ellenbogen L. | title=A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function | journal=Arzneimittelforschung | volume=30 | issue=4A | pages=702–707 | year=1980 | pmid=6254545}}</ref>


'''Felbinac''' (], or '''biphenylylacetic acid''') is a ] medicine,<ref>''The Merck Index'', 12th Edition. 3989</ref> belonging to the family of medicines known as ]s (NSAIDs) of the arylacetic acid (not arylpropionic acid) class, which is used to treat muscle inflammation and ].<ref>Description of Felbinac on Tiscali </ref> It is an active metabolite of ].<ref name="KTWE1980">{{cite journal |vauthors=Kohler C, Tolman E, Wooding W, Ellenbogen L | title=A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function | journal=Arzneimittelforschung | volume=30 | issue=4A | pages=702–707 | year=1980 | pmid=6254545}}</ref>
== Footnotes ==
{{Reflist}}


== References == ==Related compounds==
The α-methyl acid of felbinac is called ] and is used to prepare ]. The α-ethyl acid is called ] which is used to make ].
{{refbegin}}
* The Merck Index, 12th Edition. 3989
* Description of Felbinac on Tiscali
{{refend}}


==See also==
{{med-stub}}
*]

== References ==
{{Reflist}}


{{NSAIDs}} {{NSAIDs}}
{{Topical products for joint and muscular pain}} {{Topical products for joint and muscular pain}}
{{Prostanoidergics}}

]


]


{{musculoskeletal-drug-stub}}
]

Latest revision as of 22:11, 10 January 2025

Topical NSAID medication Pharmaceutical compound
Felbinac
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
Legal status
Legal status
Identifiers
IUPAC name
  • biphenyl-4-ylacetic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.024.758 Edit this at Wikidata
Chemical and physical data
FormulaC14H12O2
Molar mass212.248 g·mol
3D model (JSmol)
SMILES
  • O=C(O)Cc1ccc(cc1)c2ccccc2
InChI
  • InChI=1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16)
  • Key:QRZAKQDHEVVFRX-UHFFFAOYSA-N
  (verify)

Felbinac (INN, or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs) of the arylacetic acid (not arylpropionic acid) class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.

Related compounds

The α-methyl acid of felbinac is called biprofen and is used to prepare bifepramide. The α-ethyl acid is called xenbucin which is used to make xenthiorate.

See also

References

  1. The Merck Index, 12th Edition. 3989
  2. Description of Felbinac on Tiscali
  3. Kohler C, Tolman E, Wooding W, Ellenbogen L (1980). "A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function". Arzneimittelforschung. 30 (4A): 702–707. PMID 6254545.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)
pyrazolones /
pyrazolidines
salicylates
acetic acid derivatives
and related substances
oxicams
propionic acid
derivatives (profens)
n-arylanthranilic
acids (fenamates)
COX-2 inhibitors
(coxibs)
other
NSAID
combinations
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use.
Topical products for joint and muscular pain (M02)
Anti-inflammatory
preparations,
non-steroids
Pyrazolidines
Acetic acid
derivatives
Other
Capsaicin derivatives
Other
Prostanoid signaling modulators
Receptor
(ligands)
DP (D2)Tooltip Prostaglandin D2 receptor
DP1Tooltip Prostaglandin D2 receptor 1
DP2Tooltip Prostaglandin D2 receptor 2
EP (E2)Tooltip Prostaglandin E2 receptor
EP1Tooltip Prostaglandin EP1 receptor
EP2Tooltip Prostaglandin EP2 receptor
EP3Tooltip Prostaglandin EP3 receptor
EP4Tooltip Prostaglandin EP4 receptor
Unsorted
FP (F)Tooltip Prostaglandin F receptor
IP (I2)Tooltip Prostacyclin receptor
TP (TXA2)Tooltip Thromboxane receptor
Unsorted
Enzyme
(inhibitors)
COX
(PTGS)
PGD2STooltip Prostaglandin D synthase
PGESTooltip Prostaglandin E synthaseHQL-79
PGFSTooltip Prostaglandin F synthaseBimatoprost
PGI2STooltip Prostacyclin synthaseTranylcypromine
TXASTooltip Thromboxane A synthase
Others
See also
Receptor/signaling modulators
Leukotriene signaling modulators


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it.

Categories:
Felbinac: Difference between revisions Add topic